Merck’s First M Lab™ in Europe

| By | Laboratories, Merck

Merck, a leading science and technology company, today officially opened its new M Lab™ Collaboration Center in Molsheim, France. The center is Merck’s first in Europe and ninth worldwide, providing biopharmaceutical manufacturers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers to solve their toughest challenges and accelerate development and production of new therapies.

With the rapidly growing biopharma industry in Europe and demand for cost-effective therapies worldwide, customers will benefit from our expertise to develop processes for manufacturing drugs faster, safer and more effectively. Our investment here will accelerate the future growth of EMEA’s biopharmaceutical industry,

said Udit Batra,
member of the Merck Executive Board
and CEO, Life Science, in Molsheim today.

Merck’s newest M Lab™ Collaboration Center, which offers 4,000 square meters of space, represents a significant investment in the region. The €10 million center provides customers in Europe, the Middle East and Africa with a fully equipped, non-GMP pilot and bench scale lab and meeting center where they can work alongside Merck experts to solve their most pressing processing development challenges without impacting their production line.

The center in Molsheim is the latest in Merck’s network of centers around the world. Other M Lab™ Collaboration Centers are located in the United States, Brazil, China, South Korea, Singapore, Japan, India (where there are two labs).

Merck’s customers collaborate with the company’s technical experts, exploring new ways to increase productivity, improve processes and mitigate risks. The pilot and bench scale labs are in a space that simulates a real production environment across their process. Customers operate real equipment, evaluate their processes and can also take hands-on bioprocessing training courses, educating them on best practices and new approaches to develop, optimize and scale-up processes as well as simplify global technology transfer.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.